Zepbound is part of a medication class called dual glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide-1 (GLP-1) receptor agonists
4 Tirzepatide is administered subcutaneously at a medium dose of 7.5 mg with a range of 0.515 mg
Retatrutide is a triple agonist (GLP-1, GIP, and glucagon receptors) currently in clinical trials
In conditions like psoriasis and psoriatic arthritis, studies have shown that patients who lose weight often experience reduced disease activity
Life Sci 261:118457 Fang T, Huang S, Chen Y, Chen Z, Chen J, Hu W (2021) Glucagon like peptide-1 receptor agonists alter pancreatic and hepatic histology and regulation of endoplasmic reticulum stress in high-fat diet mouse model
If you've been denied treatment elsewhere, PlexusDx's individualized assessment may reveal that you qualify